Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.

Tzou PL, Rhee SY, Descamps D, Clutter DS, Hare B, Mor O, Grude M, Parkin N, Jordan MR, Bertagnolio S, Schapiro JM, Harrigan PR, Geretti AM, Marcelin AG, Shafer RW.

J Antimicrob Chemother. 2019 Oct 16. pii: dkz417. doi: 10.1093/jac/dkz417. [Epub ahead of print]

PMID:
31617907
2.

Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure.

Sacks JA, Fong Y, Gonzalez MP, Andreotti M, Baliga S, Garrett N, Jordan J, Karita E, Kulkarni S, Mor O, Mosha F, Ndlovu Z, Plantier JC, Saravanan S, Scott L, Peter T, Doherty M, Vojnov L.

AIDS. 2019 Oct 1;33(12):1881-1889. doi: 10.1097/QAD.0000000000002303.

PMID:
31274537
3.

Presence of Antibodies against Sindbis Virus in the Israeli Population: A Nationwide Cross-Sectional Study.

Koren R, Bassal R, Shohat T, Cohen D, Mor O, Mendelson E, Lustig Y.

Viruses. 2019 Jun 11;11(6). pii: E542. doi: 10.3390/v11060542.

4.

HIV-1/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferral.

Stoyanov E, Gozlan Y, Wax M, Levin E, Shvartz L, Shinar E, Mendelson E, Mor O.

Transfusion. 2019 Jun;59(6):2054-2060. doi: 10.1111/trf.15245. Epub 2019 Mar 20.

PMID:
30893485
5.

High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life data.

Gozlan Y, Bucris E, Shirazi R, Rakovsky A, Ben-Ari Z, Davidov Y, Veizman E, Saadi T, Braun M, Cohen-Naftaly M, Shlomai A, Shibolet O, Zigmond E, Katchman H, Menachem Y, Safadi R, Galun E, Zuckerman E, Nimer A, Hazzan R, Maor Y, Saif AM, Etzion O, Lurie Y, Mendelson E, Mor O.

Antivir Ther. 2019;24(3):221-228. doi: 10.3851/IMP3301.

PMID:
30880684
6.

Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009-2017.

Bassal R, Wax M, Shirazi R, Shohat T, Cohen D, David D, Abu-Mouch S, Abu-Ghanem Y, Mendelson E, Ben-Ari Z, Mor O.

Epidemiol Infect. 2019 Jan;147:e92. doi: 10.1017/S0950268819000062.

7.

Comparison of the new fully automated extraction platform eMAG to the MagNA PURE 96 and the well-established easyMAG for detection of common human respiratory viruses.

Hindiyeh M, Mor O, Pando R, Mannasse B, Kabat A, Assraf-Zarfati H, Mendelson E, Sofer D, Mandelboim M.

PLoS One. 2019 Feb 19;14(2):e0211079. doi: 10.1371/journal.pone.0211079. eCollection 2019.

8.

Hepatitis E in pigs in Israel: seroprevalence, molecular characterisation and potential impact on humans.

Shirazi R, Pozzi P, Wax M, Bar-Or I, Asulin E, Lustig Y, Mendelson E, Ben-Ari Z, Schwartz E, Mor O.

Euro Surveill. 2018 Dec;23(49). doi: 10.2807/1560-7917.ES.2018.23.49.1800067.

9.

Epidemiologic and phylogenetic analysis of the 2018 West Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage I.

Lustig Y, Gosinov R, Zuckerman N, Glazer Y, Orshan L, Sofer D, Schwartz E, Schvartz G, Farnoushi Y, Lublin A, Erster O, Shalom U, Yeger T, Mor O, Anis E, Mendelson E.

Euro Surveill. 2019 Jan;24(1). doi: 10.2807/1560-7917.ES.2019.24.1.1800662.

10.

Sexual intermingling of Arab and Jewish MSM in Israel: results of a molecular epidemiology study.

Zuckerman NS, Mor Z, Bucris E, Wax M, Mendelson E, Mor O.

AIDS. 2019 Feb 1;33(2):339-344. doi: 10.1097/QAD.0000000000002057.

PMID:
30325775
11.

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.

12.

Characterization of hepatitis B and delta coinfection in Israel.

Shirazi R, Ram D, Rakovsky A, Bucris E, Gozlan Y, Lustig Y, Shaked-Mishan P, Picard O, Shemer-Avni Y, Ben-Zvi H, Halutz O, Lurie Y, Veizman E, Carlebach M, Braun M, Naftaly MC, Shlomai A, Safadi R, Mendelson E, Sklan EH, Ben-Ari Z, Mor O.

BMC Infect Dis. 2018 Feb 27;18(1):97. doi: 10.1186/s12879-018-3008-x.

13.

Diagnosis of HIV-1 infection: Performance of Xpert Qual and Geenius supplemental assays in fourth generation ELISA-reactive samples.

Rakovsky A, Gozlan Y, Bassal R, Wax M, Shirazi R, Bakhanashvili M, Kra-Oz Z, Radian-Sade S, Ben-Zvi H, Schreiber L, Wolf DG, Shemer-Avni Y, Chemtob D, Mendelson E, Mor O.

J Clin Virol. 2018 Apr;101:7-10. doi: 10.1016/j.jcv.2018.01.007. Epub 2018 Jan 17.

PMID:
29414189
14.

Usutu Virus RNA in Mosquitoes, Israel, 2014-2015.

Mannasse B, Mendelson E, Orshan L, Mor O, Shalom U, Yeger T, Lustig Y.

Emerg Infect Dis. 2017 Oct;23(10):1699-1702. doi: 10.3201/eid2310.171017.

15.

Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.

Moscona R, Ram D, Wax M, Bucris E, Levy I, Mendelson E, Mor O.

J Int AIDS Soc. 2017 Aug 10;20(1):21846. doi: 10.7448/IAS.20.1.21846.

16.

Ongoing hepatitis A among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016 - June 2017.

Gozlan Y, Bar-Or I, Rakovsky A, Savion M, Amitai Z, Sheffer R, Ceder N, Anis E, Grotto I, Mendelson E, Mor O.

Euro Surveill. 2017 Jul 20;22(29). pii: 30575. doi: 10.2807/1560-7917.ES.2017.22.29.30575.

17.

Cerebral Palsy-Trends in Epidemiology and Recent Development in Prenatal Mechanisms of Disease, Treatment, and Prevention.

Stavsky M, Mor O, Mastrolia SA, Greenbaum S, Than NG, Erez O.

Front Pediatr. 2017 Feb 13;5:21. doi: 10.3389/fped.2017.00021. eCollection 2017. Review.

18.

Missed opportunities for earlier diagnosis of HIV in patients who presented with advanced HIV disease: a retrospective cohort study.

Levy I, Maor Y, Mahroum N, Olmer L, Wieder A, Litchevski V, Mor O, Rahav G.

BMJ Open. 2016 Nov 10;6(11):e012721. doi: 10.1136/bmjopen-2016-012721.

19.

HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients.

Gozlan Y, Ben-Ari Z, Moscona R, Shirazi R, Rakovsky A, Kabat A, Veizman E, Berdichevski T, Weiss P, Cohen-Ezra O, Lurie Y, Gafanovich I, Braun M, Cohen-Naftaly M, Shlomai A, Shibolet O, Zigmond E, Zuckerman E, Carmiel-Haggai M, Nimer A, Hazzan R, Maor Y, Kitay-Cohen Y, Shemer-Avni Y, Kra-Oz Z, Schreiber L, Peleg O, Sierra S, Harrigan PR, Mendelson E, Mor O.

Antivir Ther. 2017;22(5):431-441. doi: 10.3851/IMP3123. Epub 2017 Jan 9.

PMID:
28067632
20.

Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groups.

Manor Y, Lewis M, Ram D, Daudi N, Mor O, Savion M, Kra-Oz Z, Shemer Avni Y, Sheffer R, Shouval D, Mendelson E.

J Infect Dis. 2016 Dec 23. pii: jiw611. doi: 10.1093/infdis/jiw611. [Epub ahead of print]

PMID:
28013247
21.

Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.

Chowers M, Regev-Yochay G, Mor O, Cohen-Poradosu R, Riesenberg K, Zimhony O, Chemtob D, Stein M, Dagan R, Levy I.

Hum Vaccin Immunother. 2017 Jan 2;13(1):216-219. doi: 10.1080/21645515.2016.1229720.

22.

Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.

Yaari R, Kaliner E, Grotto I, Katriel G, Moran-Gilad J, Sofer D, Mendelson E, Miller E, Huppert A; POG group, Anis E, Kopel E, Manor Y, Mor O, Shulman L, Singer R, Weil M.

BMC Med. 2016 Jun 23;14(1):95. doi: 10.1186/s12916-016-0637-z. Erratum in: BMC Med. 2016;14(1):120.

23.

Hepatitis E Virus Genotype 3 in Sewage and Genotype 1 in Acute Hepatitis Cases, Israel.

Ram D, Manor Y, Gozlan Y, Schwartz E, Ben-Ari Z, Mendelson E, Mor O.

Am J Trop Med Hyg. 2016 Jul 6;95(1):216-20. doi: 10.4269/ajtmh.15-0925. Epub 2016 May 31.

24.

[RESISTANCE OF HCV TO NEW DIRECT ACTING ANTIVIRALS].

Gozlan Y, Mendelson E, Ben-Ari Z, Mor O.

Harefuah. 2015 Nov;154(11):684-7, 743. Hebrew.

PMID:
26821497
25.

Evaluation of Xpert HIV-1 Qual assay for resolution of HIV-1 infection in samples with negative or indeterminate Geenius HIV-1/2 results.

Michaeli M, Wax M, Gozlan Y, Rakovsky A, Mendelson E, Mor O.

J Clin Virol. 2016 Mar;76:1-3. doi: 10.1016/j.jcv.2015.12.009. Epub 2015 Dec 29.

PMID:
26761545
26.

Characteristics and Outcome of Patients Diagnosed With HIV at Older Age.

Asher I, Guri KM, Elbirt D, Bezalel SR, Maldarelli F, Mor O, Grossman Z, Sthoeger ZM.

Medicine (Baltimore). 2016 Jan;95(1):e2327. doi: 10.1097/MD.0000000000002327.

27.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

28.

Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load.

Mor O, Gozlan Y, Wax M, Mileguir F, Rakovsky A, Noy B, Mendelson E, Levy I.

J Clin Microbiol. 2015 Nov;53(11):3458-65. doi: 10.1128/JCM.01806-15. Epub 2015 Aug 19.

29.

Early onset preeclampsia and cerebral palsy: a double hit model?

Mor O, Stavsky M, Yitshak-Sade M, Mastrolia SA, Beer-Weisel R, Rafaeli-Yehudai T, Besser L, Hamou B, Mazor M, Erez O.

Am J Obstet Gynecol. 2016 Jan;214(1):105.e1-9. doi: 10.1016/j.ajog.2015.08.020. Epub 2015 Aug 15.

PMID:
26283455
30.

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).

Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Lepej SZ, Perno C, Boucher CA, Wensing AM; HEPVIR Working Group of the European Society for Translational Antiviral Research.

J Infect Dis. 2016 Jan 1;213(1):39-48. doi: 10.1093/infdis/jiv363. Epub 2015 Jul 1.

PMID:
26136470
31.

Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety.

Redko B, Ragozin E, Andreii B, Helena T, Amnon A, Talia SZ, Mor OH, Genady K, Gary G.

Biopolymers. 2015 Nov;104(6):743-52. doi: 10.1002/bip.22694.

PMID:
26058565
32.

Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.

Mor O, Ofir I, Pavel R, Bassal R, Kra-Oz Z, Cohen D, Shohat T, Mendelson E.

Epidemiol Infect. 2016 Jan;144(1):207-14. doi: 10.1017/S0950268815000230. Epub 2015 May 20.

PMID:
25990962
33.

Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel.

Moran-Gilad J, Mendelson E, Burns CC, Bassal R, Gdalevich M, Sofer D, Oberste MS, Shulman LM, Kaliner E, Hindiyeh M, Mor O, Shahar L, Iber J, Yishay R, Manor J, Lev B, Gamzu R, Grotto I.

J Clin Virol. 2015 May;66:51-5. doi: 10.1016/j.jcv.2015.03.005. Epub 2015 Mar 10. Erratum in: J Clin Virol. 2015 Aug;251. Hindiye, Musa [corrected to Hindiyeh, Musa].

PMID:
25866337
34.

Prevalence of hepatitis E virus antibodies, Israel, 2009-2010.

Mor O, Bassal R, Michaeli M, Wax M, Ram D, Cohen-Ezra O, Cohen D, Mendelson E, Ben-Ari Z, Shohat T.

Emerg Infect Dis. 2015 Apr;21(4):692-4. doi: 10.3201/eid2104.140245.

35.

Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory.

Ram D, Leshkowitz D, Gonzalez D, Forer R, Levy I, Chowers M, Lorber M, Hindiyeh M, Mendelson E, Mor O.

J Virol Methods. 2015 Feb;212:12-6. doi: 10.1016/j.jviromet.2014.11.003. Epub 2014 Nov 11.

PMID:
25445792
36.

Steroid-responsive, progressive, focal measles virus brain infection.

Steiner I, Livneh V, Hoffmann C, Nass D, Mor O, Chapman J.

Ann Neurol. 2014 Jun;75(6):967-70. doi: 10.1002/ana.24183. Epub 2014 Jun 19.

PMID:
24817010
37.

Evaluation of the Bio-Rad Geenius HIV 1/2 assay as an alternative to the INNO-LIA HIV 1/2 assay for confirmation of HIV infection.

Mor O, Mileguir F, Michaeli M, Levy I, Mendelson E.

J Clin Microbiol. 2014 Jul;52(7):2677-9. doi: 10.1128/JCM.01184-14. Epub 2014 Apr 30.

38.

[Relevance of HIV resistance testing for treatment decisions].

Mor O, Grossman Z, Avidor B, Turner D.

Harefuah. 2013 Apr;152(4):230-4, 245-6. Review. Hebrew.

PMID:
23844526
39.

Incidence of rash after amoxicillin treatment in children with infectious mononucleosis.

Chovel-Sella A, Ben Tov A, Lahav E, Mor O, Rudich H, Paret G, Reif S.

Pediatrics. 2013 May;131(5):e1424-7. doi: 10.1542/peds.2012-1575. Epub 2013 Apr 15.

PMID:
23589810
40.

Metachromasy as an indicator of photostabilization of methylene blue adsorbed to clays and minerals.

Samuels M, Mor O, Rytwo G.

J Photochem Photobiol B. 2013 Apr 5;121:23-6. doi: 10.1016/j.jphotobiol.2013.02.004. Epub 2013 Feb 16. Review.

PMID:
23474529
41.

Syphilis outbreak among men who have sex with men, Tel Aviv, Israel, 2008-2009.

Brosh-Nissimov T, Mor Z, Avramovich E, Katchman E, Avidor B, Mor O, Turner D.

Isr Med Assoc J. 2012 Mar;14(3):152-6.

42.

Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases.

Levy I, Mor Z, Anis E, Maayan S, Leshem E, Pollack S, Chowers M, Mor O, Riesenberg K, Sthoeger Z, Ram D, Grossman Z.

Clin Infect Dis. 2011 Jun;52(11):1363-70. doi: 10.1093/cid/cir244.

PMID:
21596678
43.

Expression of cyclooxygenase-2 in Wilms tumor: immunohistochemical study using tissue microarray methodology.

Fridman E, Pinthus JH, Kopolovic J, Ramon J, Mor O, Mor Y.

J Urol. 2006 Oct;176(4 Pt 2):1747-50.

PMID:
16945639
44.

ErbB2 is a tumor associated antigen and a suitable therapeutic target in Wilms tumor.

Pinthus JH, Fridman E, Dekel B, Goldberg I, Kaufman-Francis K, Eshhar Z, Harmelin A, Rechavi G, Mor O, Ramon J, Mor Y.

J Urol. 2004 Oct;172(4 Pt 2):1644-8.

PMID:
15371781
45.

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides.

Bar-Haim E, Paz A, Machlenkin A, Hazzan D, Tirosh B, Carmon L, Brenner B, Vadai E, Mor O, Stein A, Lemonnier FA, Tzehoval E, Eisenbach L.

Br J Cancer. 2004 Jul 19;91(2):398-407.

46.

Downregulation of gene expression in the ageing lens: a possible contributory factor in senile cataract.

Segev F, Mor O, Segev A, Belkin M, Assia EI.

Eye (Lond). 2005 Jan;19(1):80-5.

PMID:
15105821
47.

Molecular analysis of transitional cell carcinoma using cDNA microarray.

Mor O, Nativ O, Stein A, Novak L, Lehavi D, Shiboleth Y, Rozen A, Berent E, Brodsky L, Feinstein E, Rahav A, Morag K, Rothenstein D, Persi N, Mor Y, Skaliter R, Regev A.

Oncogene. 2003 Oct 23;22(48):7702-10.

PMID:
14576834
48.

Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.

Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R, Feinstein E.

Mol Cell Biol. 2002 Apr;22(7):2283-93.

49.

Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.

Rozovskaia T, Feinstein E, Mor O, Foa R, Blechman J, Nakamura T, Croce CM, Cimino G, Canaani E.

Oncogene. 2001 Feb 15;20(7):874-8.

50.

The human Surfeit locus.

Duhig T, Ruhrberg C, Mor O, Fried M.

Genomics. 1998 Aug 15;52(1):72-8.

PMID:
9740673

Supplemental Content

Support Center